CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $613,506
- in 6 filings
Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-03-31 | Diep Tuan Tu Chief Operating Officer | Returned to the company · Stock Option (Right to Buy) | −75,000 | 0 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −250,000 | 0 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −36,000 | 0 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +12,360 | 12,360 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −12,360 | 0 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −650,000 | 0 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +9,013 | 9,013 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −9,013 | 0 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +21,586 | 21,586 | ||
| 2026-03-31 | DHILLON PUNIT Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −21,586 | 0 | ||
| 2026-02-06 | Schwab Andrew J. Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2026-02-06 | Grayson Paul A. Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2026-02-06 | Smith Karen L. Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2026-02-06 | ARSENAULT KAITLYN Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 |
Page 4 of 15 · 292 trades